Ernexa Therapeutics (ERNA) Leases (2018 - 2025)
Historic Leases for Ernexa Therapeutics (ERNA) over the last 13 years, with Q3 2025 value amounting to $541000.0.
- Ernexa Therapeutics' Leases fell 2475.66% to $541000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $541000.0, marking a year-over-year decrease of 2475.66%. This contributed to the annual value of $670000.0 for FY2024, which is 9795.61% down from last year.
- Per Ernexa Therapeutics' latest filing, its Leases stood at $541000.0 for Q3 2025, which was down 2475.66% from $581000.0 recorded in Q2 2025.
- Ernexa Therapeutics' Leases' 5-year high stood at $36.5 million during Q1 2024, with a 5-year trough of $541000.0 in Q3 2025.
- Its 5-year average for Leases is $11.3 million, with a median of $1.9 million in 2022.
- As far as peak fluctuations go, Ernexa Therapeutics' Leases skyrocketed by 1015318.46% in 2021, and later tumbled by 9838.57% in 2025.
- Ernexa Therapeutics' Leases (Quarter) stood at $2.7 million in 2021, then plummeted by 61.36% to $1.0 million in 2022, then soared by 3082.62% to $32.8 million in 2023, then plummeted by 97.96% to $670000.0 in 2024, then fell by 19.25% to $541000.0 in 2025.
- Its last three reported values are $541000.0 in Q3 2025, $581000.0 for Q2 2025, and $619000.0 during Q1 2025.